Abstract:Matrix metalloproteinase-9 (MMP-9) and heparanase (HPSE) are thought to be involved in tumor progression and metastasis. However, up to now, there are no studies that simultaneously investigated the expression levels of MMP-9 and HPSE in tumor tissue and serum of breast cancer patients. Their correlation in breast cancer pathological processes is unknown. The purpose of this study was to investigate the expression profile of MMP-9 and HPSE in breast cancer and to assess their clinicopathological significance. We measured serum MMP-9 and HPSE by enzyme-linked immunosorbent assay in healthy women, and in patients with benign and malignant breast disease. We also evaluated the expression of MMP-9 and HPSE protein in paraffin-embedded tumor tissues by immunohistochemistry. We then correlated serum and tissue levels of MMP-9 and HPSE in breast cancer samples and their expression with patients' clinicopathologic characteristics. We found that serum levels of MMP-9 and HPSE were significantly higher in breast cancer patients than in benign breast disease and in healthy controls (P = 0.001). There was positive correlation between MMP-9 and HPSE in breast cancer patients. The tissue and serum levels of MMP-9 were associated with histology grade, lymph node status, pathological stage, and lymphovascular invasion (all P < 0.05). The tissue levels of MMP-9 were also associated with ER (P = 0.038) and Ki-67 (P = 0.032). The tissue and serum levels of HPSE expression were associated with tumor size, histology grade, lymph node status, and pathological stage (all P < 0.05). Our findings suggested that MMP-9 and HPSE might further be evaluated as biomarkers for predicting progression and prognosis of breast cancer.

Relationship between the clinicopathological characteristics and the expression of MMP9 in breast cancer

Expression of Matrix Metalloproteinase-9 and Their Correlation with Tumor Invasion, Metastasis in Gastric Carcinoma

The expression of tumor metastasis suppressor gene KAI1 and matrix metalloproteinase 2 in breast cancer tissues

Expressions of MMP-9 and PEDF and Their Correlation with Tumor Invasion and Lymph Node Metastasis in Gastric Carcinoma

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

The Expression and Clinical Significance of MMP-9 in Pancreatic Cancer

Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.

Clinical Significance of the Expression of Osteopontin and MMP-9 in Breast Cancer

Expression of MMP-9 in Cervical Intraepithelial Neoplasia and Cervical Carcinoma

Expression of extracellular matrix metalloproteinase inducer CD147 and MMP-9 in hepatocellular carcinoma and its clinical significance

The Expression of Transferrin and MMP-9 in Breast Cancer and Its Significance in Prognosis

Expressions and significance of PCNA and MMP9 in cervix cancer tissue

Expression and Prognostic Value of Matrix Metalloproteinases-9 (MMP-9) in Lymph Node-Negative Breast Carcinoma

Relationship Between Expression of MMP-9 and TIMP-1 and Cancer Cell Proliferation,Invasion and Metastasis in Invasive Carcinoma of Cervix

Relationship between the expressions of MMP-7,MMP-9 and the abdominal cavity metastasis in colorectal carcinoma

The Expression of MMP-9 Protein is Associated with Lymph Node Metastasis of Breast Carcinoma

Expression and Correlation of Matrix Metalloproteinase-9 and Heparanase in Patients with Breast Cancer

The expression and significance of MMP-9 in cervical cancer

Expression and significance of PTEN, MMP-9 and p27kip1 in breast cancer

Expression and CD147,MMP-9 and P-Erk in Invasive Ductal Carcinoma of Breast and Its Significance

The expression of MMP2 and MMP9 in endometrial carcinoma